KPEL
Thesis: Low-PE renewable execution with strong revenue growth and a valuation that still leaves room for rerating.
Buy rule: Build first while valuation remains a small-cap growth bargain and receivables stay controlled.
Break rule: Trim if project execution slips, receivables stretch, or group complexity starts driving the story.
DHABRIYA
Thesis: Microcap quality candidate with PAT doubling, expanded EBITDA margin and a still-sane valuation base.
Buy rule: Build after confirming liquidity; add only if FY26 keeps the new margin band intact.
Break rule: Reduce if inventory, debt or receivables absorb the reported earnings growth.
PIGL
Thesis: Order book is materially larger than market cap, with RDSS work and Peaton busduct optionality.
Buy rule: Build capped exposure only while PAT margin begins catching up with revenue growth.
Break rule: Do not average down if orders convert into low-margin working-capital strain.
JNKINDIA
Thesis: Q3 revenue and PAT acceleration show that order visibility is already touching reported earnings.
Buy rule: Start now; scale only after the next result confirms conversion without debtor blowout.
Break rule: Reduce if receivables expand faster than sales or order conversion stalls.
DYCL
Thesis: Mid-teens valuation, PAT growth, order visibility and solar DC/e-beam capacity provide a second trigger.
Buy rule: Build measured exposure; add if order inflow, spreads and capacity ramp remain disciplined.
Break rule: Trim if cable spreads turn, receivables worsen, or capacity ramp disappoints.
TEMBO
Thesis: Large order book and scaled 9M profit create upside, but cash-flow and governance risks cap sizing.
Buy rule: Hold as option-sized exposure; do not average up without cash-flow and governance proof.
Break rule: Reduce quickly on weak operating cash flow, guarantees, related-party issues or dilution.